Effective tools for male contraception are important in the control of reproduction in animal populations. The aim of the present study was to evaluate the effects of active immunization against gonadotropin-releasing hormone (GnRH) on male reproductive function assessing testicular morphological changes and serum-gonadotropin levels in pre-pubertal rabbits, guinea pigs and ram lambs. An anti-GnRH vaccine was developed by linking a GnRH-homologous molecule to a tetanus clostridial toxoid (Al(OH)3 coadjuvant). After vaccination protocols testicular morphometry, histopathological alterations and endocrine responses (FSH, LH, testosterone and cortisol serum levels) were evaluated. Testicular volume was significantly reduced in vaccinated animals with respect to the control group in rabbits, guinea pigs and ram lambs (P<0.05 to P<0.001). The anti-GnRH vaccine generated a reduction in testicular volume of 15-, 27- and 11-fold, respectively. Tubule diameters decreased in the vaccinated group with respect to the control ~2.0-, 1.2- and 3.5-fold, respectively (P<0.001). Tubule, intertubular and lumen volumes significantly decreased in vaccinated rabbits (P<0.05), guinea pigs and ram lambs (P<0.01). Vaccinated animals of the three species showed significant reductions in spermatogonial numbers (10- to 40-fold; P<0.01). Sperm was absent in all seminiferous tubules of all rabbits, and most individuals of guinea pigs (80%) and ram lambs (60%). No significant differences were observed between vaccinated and control groups regarding FSH and LH during the experiments in the three experimental species/models used. Testosterone, however, was only significantly lower (~22-fold, P<0.01) in vaccinated rabbits. In conclusion, the present study demonstrated that pre-pubertal active immunization against GnRH leads to endocrine disruption and marked differences on testicular morphometry, development and activity among lagomorphs, hystricomorphs and ovine species with species-specific sensitivity regarding the anti-GnRH immune response.

The interaction between dietary balanced protein, ractopamine (RAC) and Improvac (IMP) on the growth response of 120 individually penned male PIC© pigs was evaluated. The pigs entered the trial at 16 weeks of age and were assigned to 12 treatments using a 2×2×3 factorial design. Three balanced protein diets, formulated with standard illeal digestible lysine levels of 7.50 (low), 9.79 (medium) and 12.07 g/kg (high), were fed from 20 weeks. Improvac was administered at 16 and 20 weeks, the booster being given 4 weeks before slaughter. Ractopamine was supplemented at 10 mg/kg to the applicable treatments from 20 weeks. Live weight, backfat depth and food intake were measured on a weekly basis. Primary vaccination had no influence on the parameters measured. Immunocastration, RAC and higher protein diet treatments increased weight gain, but food intake was increased only with the use of IMP. Although weight gain increased in IMP-treated males, the increased feed intake resulted in their feed conversion efficiencies (FCE) being inferior to the intact controls. Feeding RAC only benefitted FCE when a high or medium protein diet was fed. Immunocastrates deposited more backfat after the booster vaccination than did entire males. Thus the cost of using RAC, IMP and of increasing dietary protein content needs to be weighed up against the additional revenue generated through the use of these interventions.

Immunocastration or vaccination against boar taint can be used as alternative for surgical castration of male piglets. The vaccine is administrated twice. After the second vaccination (V2), the pigs behave like barrows instead of boars and their feed intake increases which may result in a lower lean meat percentage. The timing of V2 is therefore crucial to find the right balance between the advantages of entire males and barrows. In this study, we evaluated the effect of time post second injection within the advised time frame (4 v. 6 weeks before slaughter) on behaviour, performance, carcass and meat quality of immunocastrated male pigs. In total, 180 animals (hybrid sow×Piétrain): 60 gilts, 60 male pigs vaccinated 6 weeks before slaughter (IM-6) and 60 male pigs vaccinated 4 weeks before slaughter (IM-4), all slaughtered at comparable slaughter weights. After 20 weeks of age, IM-6 showed more inactive behaviour at the expense of playing and aggressive behaviour. Daily feed intake (DFI), daily gain (DG) and feed conversion ratio (FCR) did not differ significantly between IM-6 and IM-4. Gilts had a lower DFI and DG in the late finishing phase and a higher FCR overall compared with both IM groups. Gilts showed a higher lean meat content compared with both IM groups. Earlier vaccination increased dressing percentage, which could partly be explained by the lower weight of the gastrointestinal tract, but not by testes weight. Meat quality traits and palatability did not differ significantly between IM-6 and IM-4. Vaccination of immunocastrates at 6 compared with 4 weeks before slaughter improved the calmness in the stable and the dressing percentage, while maintaining performance and carcass characteristics.

The main objective of the implementation of artificial insemination (AI) in cattle is to produce a sustained genetic progress in the herd. Although AI is an old reproductive biotechnology, its widespread implementation is very recent and is mainly because of the use of protocols that allows AI without oestrus detection, commonly called fixed-time artificial insemination (FTAI). The development of FTAI protocols also allowed the application of AI in larger, extensively managed herds and especially in suckled cows instead of restricting the breeding programmes to the heifers. Fixed-time AI treatments are widely used in South America, with about 3 000 000 cows inseminated in the last season in Argentina and about 8 000 000 in Brazil. The objective of this review is to present and describe the various treatments available and some of the factors that may affect pregnancy rates in beef cattle.

Gonadotropin releasing hormone (GnRH)-secreting neurons in mammal's project principally to the median eminence-arcuate (ME-ARC) region where they make contact with basal lamina and open into the pericapillary space of the primary hypophyseal portal plexus. In the present study we report the expression of polysialylated form of neural cell adhesion molecule (PSA-NCAM) on the cell bodies of GnRH-secreting neurons and on glial cells in the medial preoptic area (mPOA) of the hypothalamus in both the proestrous and diestrous phases of cycling rats, using dual immunohistofluorescent staining. Regulation of PSA-NCAM occurs via regulation of PSA biosynthesis by the polysialyltransferase enzyme (PST-1). Therefore, we studied the expression of PST mRNA and GnRH in GnRH-releasing cell bodies by combining fluorescent in situ hybridization with immunohistofluorescence, and expression of PST mRNA in the mPOA using northern blotting. We observed dynamic upregulation of PSA-NCAM on GnRH cell bodies in the proestrous phase, accompanied by enhanced expression of PST-1 mRNA. The present results indicate that PSA-NCAM has a permissive role in the structural remodeling of GnRH neurons. Enhanced expression of mRNA encoding PST-1 in the proestrous phase indicates that the biosynthesis of PSA and, thus, PSA-NCAM is regulated at the transcriptional level.

This study was conducted to verify the effect(s) of melatonin treatment on frog Leydig cells. Morphological observation after melatonin treatment indicates that many frog Leydig cells show degenerative changes (i.e. heterochromatic nuclei, loss of cellular adhesion) while in adjacent germinal tubules several Sertoli cells show heterochromatic nuclei, confirming the presence of a paracrine effect between interstitial and germinal compartments. The effect of melatonin on frog Leydig cell steroidogenesis was investigated in in vitro experiments; after 6 h of incubation melatonin severely inhibits both control and GnRH-induced testosterone secretion. In addition, in order to verify the effect of indolamine on frog Leydig cell activity, we investigated, by in situ hybridization, the presence of frog relaxin (fRLX, a transcript specifically expressed by these cells) in the testes of melatonin-injected animals after 48 h. fRLX signal completely disappeared from the testis of melatonin-injected frogs. The results of the present study indicate that melatonin treatment provokes Leydig cell morphological changes, blocks GnRH-antagonist-induced testosterone secretion and decreases fRLX expression. Taken together these results strongly indicate that melatonin acts on Leydig cells in the testis of the frog Rana esculenta.

This study was aimed at developing a hormonal treatment protocol in order to optimize the proportion of pronuclear-stage embryos to be used for DNA microinjection in a goat transgenic founder production programme. A total of 46 adult BELE® and 47 adult standard goats (1–5 years old) were used as donors and recipients, respectively. They were heat-synchronized using intravaginal sponges containing 60 mg medroxyprogesterone acetate for 10 days with an injection of 125 μg cloprostenol on the morning of the eighth day. Recipients were injected with 400 IU eCG at the time of sponge removal while donors received a total of 133 mg NIH-FSH-P1 (Folltropin-V) given twice daily in decreasing doses over 3 days starting 48 h before sponge removal. Ovulation was induced in donors by injecting 100 μg of GnRH at 24 h (GnRH24) or 36 h (GnRH36) after sponge removal. Embryo recovery was performed by oviduct flushing following a standard mid-ventral laparotomy procedure. The proportion of embryos in the pronuclear stage of development was higher in the GnRH36 group (90% vs 34%, p<0.01). Embryos were microinjected with a DNA expression cassette followed by transfer to the oviduct of synchronized recipients. A higher, yet not statistically significant, pregnancy rate was found in the recipients transferred with pronuclear-stage embryos compared with those transferred with 2-cell-stage embryos (64% vs 37%, chi-square p=0.06). One transgenic female founder was produced from the group of recipients transferred with pronuclear-stage microinjected embryos.

Using primiparous autumn-lambing ewes, this study investigated nutritional effects on (i) pulsatile LH secretion, (ii) responsiveness of the pituitary-ovarian axis to exogenous GnRH, and (iii) oestrus and ovarian cyclicity during the early post-partum period. At lambing (25 October ± 0·3 days), 32 primiparous ewes rearing 2·1 ± 0·04 lambs were equally allocated to four dietary treatments in a 2 ✕ 2 factorial designed experiment. Diets comprised ad libitum hay and 1·5 kg per ewe per day of one of four concentrates (12·5 MJ metabolizable energy per kg dry matter) containing either fibrous (F) or starchy (S) ingredients with (P) or without (O) the inclusion of 120 g/kg fish meal. Throughout the study (lambing to 17 December) ewe body condition score was assessed and ewes and their lambs were weighed at weekly intervals. Blood samples were obtained from all ewes to measure circulating concentrations of progesterone and oestrous behaviour was monitored using vasectomized rams. On day 12 post partum, blood samples were obtained from all ewes at 2-h intervals (09:00 to 17:00 h) to measure concentrations of insulin and urea nitrogen, and at 15-min intervals (09:00 to 21:00 h) to measure pulsatile LH secretion. All ewes received 25 i. v. injections of GnRH (250 ng GnRH in 2 ml 0·9% saline) at 2-h intervals commencing 4 h before the end of the 15-min blood sampling period and their ovaries were examined via laparoscopy on day 17 post partum. There was no effect of dietary treatment on ewe live weight or body condition score throughout the study but inclusion of fish meal in the ewe diet increased lamb growth (FP/SP 255 (s.e. 8·9) v. FO/SO 234 (s.e. 8·2) g/day, P < 0·05). Circulating concentrations of insulin on day 12 post partum were lower in ewes given the fibrous compared with the starchy diets (P < 0·05) while dietary inclusion of fish meal increased (P < 0·001) urea nitrogen. Pulsatile LH secretion on day 12 post partum was not affected by dietary treatment. For ewes on diets F P, FO, SP and SO, the numbers that experienced an LH surge during the period of GnRH administration were 1, 2, 1 and 0, and that ovulated by day 17 post partum were 3, 5, 0 and 5 (FP/SP v. FO/SO, P < 0·05) respectively. Dietary treatment did not affect the intervals from parturition to the onset of ovarian cyclicity or oestrus (overall means were 23 (s.e.1·0) days and 38 (s.e.1·6) days respectively) but ewes on the fibrous compared with the starchy diet had a higher (P < 0·05) incidence of short (≤ 10 days) first ovarian cycles. Results of this study, which involved young growing animals, demonstrate that (i) inclusion of fish meal in the ewe diet influenced the sensitivity of the pituitary-ovarian axis to exogenous GnRH, and (ii) a fibrous compared with a starchy diet was associated with an increased incidence of premature luteal regression.

The objective was to evaluate different oestrous synchronization schemes in beef cattle under range conditions. In experiment 1, 202 heifers averaging 26 months of age were assigned randomly to three treatments: (a) GnRH-PG. (no. = 44) day 0 (D0): injection of GnRH; D7: injection of PGF2α; D0 to D25 oestrous detection (OD) and artificial insemination (AI); (b) OD-PG. (no. = 45) D0 to D4; OD + AI; D5: injection of PGF2α; D5 to D25 OD + AI; and (c)Ovsynch. (no. = 113) D0: injection of GnRH; D7: injection of PGF2α; D9: injection of GnRH and 16 h later AI at fixed time. In experiment 2, 318 non-suckling cows were assigned randomly to three treatments: (a) GnRH-PG. (no. = 106) D0: injection of GnRH; D7: injection of PGF2α; D0 to D25 OD + AI; (b) GnRH-MAP-PG. (no. = 106) D0: injection of a GnRH analogue and insertion of an intravaginal sponge impregnated with 250 mg of medroxyprogesterone acetate; D7: injection of PGF2α and sponge withdrawal; D0 to D25 OD + AI; (c) controls. (no. = 106) OD and AI. The experimental period lasted 25 days and, with exception of the Ovsynch treatment, oestrous detection was carried out twice a day (a.m./p.m.) and inseminations performed 12 h later. The pregnancy rates assessed by ultrasonography 30 days after AI were: experiment 1: (a) 30·0%; (b) 28·6% and (c) 62·3% (P < 0·05); experiment 2: (a) 60·2%; (b) 57·8% and (c) 45·5% (P < 0·05). It is concluded that in heifers and non-suckling cows, oestrous synchronization treatments result in higher pregnancy rates. In non-suckling cows, the addition of a progestagen did not improve the response.

The effect of recombinant bovine FSH (rbFSH) administration on serum FSH and follicular growth was determined in 16 GnRH-immunized heifers (primary day 0 and booster day 28 using 0·4 mg human serum albumin (HSA) – Cys-Gly-GnRH in DEAE-dextran). All heifers produced GnRH antibody titres (mean 58·8 (s.e. 2·8)% binding at 1: 640 serum dilution on day 42), follicular growth ceased (follicles ≤ 4 mm) between days 33 and 49, progesterone concentrations were ≤ 0·5 ng/ml in all heifers by day 53, and pulsatile LH secretion was markedly reduced (v. luteal phase control heifers) on day 63. Heifers were blocked by antibody titre and LH concentrations on day 63 and assigned (no. = five or six per treatment) on day 78 to: (1) control (saline given i.m. four times per day for 4 days), (2) 0·5 mg equivalent (USDA bFSH BP 1) of rbFSH (Granada Biosciences, TX) given i.m. four times per day for 6 days (12 mg in total) or 3) 1·5 mg rbFSH given i.m. four times per day for 4 days (24 mg in total). Ovaries of heifers were examined by ultrasound and blood samples were collected at 3- to 6-h intervals from days –1 to 10 and then twice a day until follicles ≥ 5 mm were no longer detectable. The increase in serum FSH concentrations was different (P < 0·05) between treatments (mean peak FSH above pre-treatment baseline concentrations at 102 h after first rbFSH were 1·4 (s.e. 0·8), 14·5 (s.e. 3·3) and 33·6 (s.e. 5·3) ng/ml for treatments 1 to 3, respectively). The rate of decline in FSH from 102 to 302 h was not different between treatments 2 and 3. There was no detectable follicular growth in heifers given saline injections. Following either rbFSH treatment, medium (MF; 5 to 9 mm) and large (LF; ≥ 10 mm) follicles grew. For heifers in treatments 2 and 3, there was no difference in the interval from start of rbFSH until the first appearance of MF (4·2 (s.e. 0·7) v. 3·3 (s.e. 0·3) days) or LF (5·3 (s.e. 0·3) v. 4·8 (s.e. 0·8) days) or in the duration of the presence of MF and/or LF (13·2 (s.e. 4·5) v. 16·6 (s.e. 2·6) days). Increasing dose of rbFSH increased (P < 0·05) the mean maximum number of MF (4·3 (s.e. 1·1) and 9·2 (s.e.0·9) for treatments 2 and 3) and LF (2·0 (s.e. 1·1) and 8·4 (s.e. 1·2)). In summary, low doses of rbFSH induced a small cohort of follicles to grow and develop without selection or development of a single dominant follicle, whereas high doses of rbFSH resulted in large numbers of both MF and LF.

The giant mole-rat Cryptomys mechowi exhibits an extreme reproductive division of labour. Reproduction in the colony is restricted to a single breeding pair. Non-reproductive individuals do not breed unless removed from the colony and paired with unfamiliar conspecifics. Circulating basal concentrations of luteinizing hormone (LH) as well as LH levels measured in response to a single exogenous gonadotropin hormone (GnRH) challenge are not significantly different between the reproductive and non-reproductive groups of either sex. Neither non-reproductive males nor females are physiologically suppressed at the level of the pituitary, as they do not exhibit a reduced pituitary secretion of LH or decreased sensitivity to hypothalamic GnRH. Rather, reproductive skew seems to result from an inhibition to mate with familiar conspecifics. Familiar individuals housed in the absence of the breeding pair did not breed, whereas pairing unfamiliar individuals of the opposite sex resulted in sexual activity and recruitment. The results from the giant mole-rat suggest that reproductive skew may result from a predominantly behavioural repression in non-reproductive females arising from an incest avoidance mechanism.

To determine the effect of different levels of gonadotropin-releasing hormone (GnRH) antibody titres (AT) on plasma hormone concentrations, behaviour, testes size and performance, Friesian bull calves (no. = 72) were immunized against either human serum albumin (HSA) conjugated to Cys-Gly-GnRH (no. = 48; immunized) or HSA (no. = 24; controls) at 8 to 10 weeks of age. One booster immunization was administered on either day 28 or 56 (no. = 24 GnRH-immunized and no. = 12 control per booster day). Based on AT 1 week post respective booster, 12 immunized and six control bulls were allocated to one of three AT groups, control (C), medium (M) and high (H) with mean AT of 0·3 (s.e. 0·1), 32 (s.e. 2) and 51 (s.e. 2)% binding at a plasma dilution of 1: 160; respectively. Bulls were blood sampled and weighed every 14 days, and testicular measurements taken every 28 days, from days 0 to 533. Behaviour was observed for 4 h once weekly while bulls were together at pasture and, within AT group, for 20 min 1 week before slaughter. At slaughter, testes and carcass measurements were made. Appropriate data were analysed by ANOVA and correlation coefficients (i) determined. Behavioural data were analysed using x2. Mean AT for M and H treatment groups during the experiment were 36·5 and 44·8% binding at a 1: 160 dilution (P > 0·05, pooled s.e.d. 5·9%), respectively. Level of AT decreased (P < 0·05) mean testosterone concentrations (1·74, 1·36 and 1·21 (s.e.d. 0·17) ng/ml for the C, M and H treatment groups, respectively) and testes size (e.g. length, 10·0, 8·9 and 8·1 (s.e.d. OS) cm) in the M and H groups compared with the C bulls. There was no effect of AT level on luteinizing hormone and insulin-like growth factor-1 concentrations or on average daily gain. Bulls in the M group had the lightest testes and lowest masculinity score compared with the C and H groups (both P < 0·05). Bulls in the H group had greater backfat thickness than the C bulls (P < 0·05). Bulls in the M and H groups were less aggressive and sexually active than the C bulls (P < 0·05). In conclusion, GnRH AT in both the M and H groups persisted for the duration of the experiment, and these AT were significantly different for a critical period pre-puberty; however they both had similar effects and caused extended periods of reduced testes growth, testosterone concentrations, and aggressive and sexual behaviour compared with C bulls but there was no detrimental effect of AT on growth or carcass characteristics.

The main objective of the present experiment was to investigate whether progesterone priming eliminates defective luteal function in seasonally anoestrous ewes induced to ovulate with pulsatile GnRH treatment by synchronizing the early stages of follicle development. This was achieved by suppressing and synchronizing the early stages of follicle development with bovine follicular fluid (bFF) and then investigating whether this was sufficient to eliminate defective luteal function following the induction of ovulation with GnRH. Ewes in group 1 (no. = 10) were injected s.c. with 2 ml bFF at 8-h intervals for a period of 3 days before the start of GnRH treatment. Animals in group 2 (no. = 10), ivhich served as positive controls, were given a single i.m. injection of 20 mg progesterone 3 days before the start of GnRH treatment, while those in group 3 (no. = 10), which served as negative controls, were injected with corn oil alone at this time. Ewes in all the three groups were induced to ovulate by administration of 2-hourly injections of GnRH (250 ng per injection) for 54 h. Frequent blood samples for LH, FSH, and oestradiol were collected around the time of both progesterone/bFF injections and GnRH treatment, as well as daily thereafter to monitor luteal function.

The bFF injections given to animals in group 1 resulted in a significant (P<0·001) suppression of FSH concentrations, followed by a rebound rise in concentrations after the cessation of treatment. GnRH treatment significantly (P < 0·05) increased both mean LH pulse amplitude and overall mean LH concentrations in all the three groups, while LH pulse frequency was increased only in non-bFF-treated ewes. Plasma oestradiol concentrations 24 h after the start of GnRH treatment were significantly (P < 0·05) higher in groups 2 and 3 compared with group 1. These differences in the patterns of oestradiol concentrations over time were associated with a significant (P <0·05) delay in the onset of the pre-ovulatory LH surge in ewes treated witli bFF (group 1). However, there was no difference in either the duration or the height of pre-ovulatory LH surge between the three treatment groups. Ewes in all three treatment groups ovulated in response to GnRH treatment. However, both laparoscopic examination and plasma progesterone concentrations revealed that the incidence of normal luteal function was significantly (P < 0·05) higher in group 2 (10/10) compared with groups 1 (2/10) and 3 (4/10), with no difference between groups 1 and 3. Overall, these results suggest that progesterone priming does not eliminate defective luteal function through synchronizing early stages offollicle development.

The main objective of the experiment was to investigate the mechanism by which progesterone priming eliminates defective luteal function in anoestrous ewes induced to ovulate with GnRH. Animals in group 1 (no. = 10) were primed with a single i.m. injection of progesterone in corn oil 3 days before the start of GnRH treatment, while ewes in group 2 (no. = 10) received corn oil alone and served as untreated controls. Ewes in group 3 (no. = 10), which served as positive controls, were treated with an intra-vaginal progestagen sponge for 7 days, and this was removed just before the start of GnRH treatment. Ewes in all three groups were induced to ovulate by administration of 2-h injections of GnRH (250 ng per injection) for 54 h. Frequent blood samples for LH, FSH and progesterone analysis were taken around the time of both progesterone injection and GnRH treatment, as well as daily thereafter to monitor luteal function, and laparoscopy was performed 3 and 7 days after GnRH treatment.

The incidence of ovulation was similar for all the three groups (8/10, 7/10 and 9/10 for groups 1, 2 and 3 respectively). Hoioever, both laparoscopic examination and plasma progesterone concentrations revealed that the incidence of normal luteal function was significantly higher in progesterone-primed animals group 1:7/8; group 3:9/9) compared ivith controls (group 2:0/7), P < 0-05) with no difference between groups 1 and 3. Injection of progesterone on day −3 significantly suppressed mean LH concentrations (P < 0·05), but mean FSH concentrations were not altered. However, there were no significant differences between groups in LH and FSH concentrations over the period of GnRH treatment, nor in the timing, duration and height of pre-ovulatory LH and FSH surges. These results suggest that progesterone priming may eliminate defective luteal function either by changing LH concentrations at the time of progesterone administration or through mechanisms not involving gonadotropin secretion.

Data from two experiments are reported which test the hypothesis that nutrient and/or dry-matter intake and body condition may interact to modify hypothalamic opioidergic activity and thus influence the pulsatile release of LH during the early post-partum period and during the oestrous cycle. Experiment 1 involved 16 multiparous, twin-suckling beef cows, and was a 2 × 2 × 2 factorial design in which the factors were level of post-partum energy intake (80 v. 130 M) metabolizable energy (ME) per day), the digestible undegradable protein (DUP) content of the post-partum diet (14 v. 31 g/kg dry matter), and treatment with either 200 mg or 400 mg naloxone hydrochloride. Blood samples were collected at 15-min intervals for 4h at weeks 4 and 7 post partum. Naloxone was administered intravenously after the eighth sample. Experiment 2 involved 16 cyclic maiden heifers and was also arranged in a factorial manner, with two levels of body condition at the start of the experimental period (2·50 and 3·16 units) and two levels of energy intake thereafter (40 and 80 MJ ME per day). Seven blood samples were collected at 15-min intervals on 4 days consecutively during the mid-luteal phase of the oestrous cycle. On the first 2 of these 4 days naloxone was administered, whilst on the last 2 days a gonadotropin-releasing hormone agonist (buserelin; GnRH) was administered, both after the fourth sample. Plasma from both experiments was assayed for LH and prolactin (Prl).

In experiment 1, cows on 130 MJ ME per day returned to oestrus and ovulated earlier than cows on 80 MJ ME per day (44·5 v. 55·0 days; s.e.d. = 3·93; P < 0·05). At week 4 post partum the proportional increase in plasma LH following naloxone challenge was greater for cows on 130 MJ ME per day than cows on 80 MJ ME per day (1·38 v. 1·12; P < 0·05), but the converse was true at week 7 (1·15 v. 1·68; P < 0·05). Cows on the high DUP diet required a higher dose of naloxone to elicit an LH response. Few heifers in experiment 2 exhibited an LH response to naloxone. In contrast, there were significant dietary treatment effects on the LH response to GnRH (P < 0·01). Relatively thin heifers on 40 MJ ME per day exhibited the lowest proportional increases in plasma LH to GnRH challenge, whereas heifers on 80 MJ ME per day and given the higher dose of GnRH produced the greatest plasma LH responses. Mean Prl concentrations before and after feeding in experiment 2 were respectively 13·2 and 10·2 ng/l (P < 0·01).

Suckled cows given a high energy diet during the early post-partum period can overcome the opioid mediated block on LH release and resume oestrous cycles earlier than cows given a low energy diet. LH would appear to be inhibited by a non-opioid mechanism in mid-luteal phase heifers. Total pituitary reserves ofLH may be influenced by the animals nutritional status.

An investigation was conducted to determine the effects of treatment with the GnRH agonist buserelin on day 12 post mating on the reproductive performance of ewes. There was a non-significant (P > 0·05) increase in nonreturn rate (control 0·76 v. buserelin 0·83) and litter size (control 1·51 v. buserelin 1·77) in three flocks. However, there was a significant (P < 0·05) increase in the number of twin lambs born (control 20 v. buserelin 40) and litter size (control 1·44 v. buserelin 1·68) in the yearling flock. There was no effect of buserelin on oestrous cycle length, although there was a tendency for treated animals to have a longer gestation length and heavier lambs. In a ewe lamb flock there was no effect of buserelin on non-return rate or litter size assessed post slaughter on day 31 of pregnancy. However, ovulation rate tended to be greater in the treated animals, which suggests that buserelin may have induced the formation of accessory corpora lutea. These results indicate that buserelin treatment improves embryo survival and that this effect is particularly evident in yearling ewes.

Forty-six Simmental × British Friesian bull calves were allocated to six treatment groups. In four groups (each of eight animals) half the animals were given a prime injection of gonadotropin-hormone-releasing-hormone (GnRH) either as the decapeptide or as an octapeptide (residues 3 to 10) conjugated to egg albumen. Prime injection times were at 3, 4, 5 or 6 months of age. All animals were boosted with a GnRH conjugate, similar to that used for the prime injection, at 8 months. At 8 months, six other animals were surgically castrated while the remaining eight were left as untreated bull controls. Weight gain and consumption of a barley-based diet offered ad libitum were recorded for individual animals. Blood samples were taken at a minimum of fortnightly intervals and the serum analysed for antibody titre against GnRH, testosterone and insulin-like growth factor 1 (IGF-1). Animals were slaughtered at 12 months and chemical analyses performed on the dissectible material of the 10th rib for protein, lipid, ash and water content. Greater antibody titres and a longer period of low serum testosterone were achieved with the octapeptide conjugate compared with the decapeptide. Serum IGF-1 slowly decreased following both surgical- and effective immuno-castration. There were no significant differences in food intake between the groups. Both steers and the more responsive immunocastrates had higher fat (P < 0·01), lower protein (P < 0·05) and water concentrations (P < 0·01) in tissues from a rib sample joint compared with untreated bulls. As immuno-responsiveness decreased there were indications of compensatory changes in body composition. The technique may be applicable during periods of, for example, mixed grazing for bulls.

As in the female (Breton et al., 1988), plasma gonadotropin levels (GtH) in male roach were always the lowest the day of aggregation on the spawning areas, eventhough they were elevated 3 daysearlier. The levels increased during spawning and remained at a high level in most of the animalscaptured out of the visible spwaning areas, 3 weeks after the beginning of the spawning activity. During the same period the GnRH contents did not significantly vary in the hypothalamic lobes, the di-met-and myelencephalon. On the contrary there were marked variations in the pituitary gland and the telencephalon in which the GnRH levels were the highest the day of aggregation when GtH plasma levels were the lowest. In these two structures they decreased during spawning in correlation with the increase of the plasma GtH levels. These results are discussed in comparison with those obtained in the female and in relation with the possible endocrine and paracrine roles of the GnRH in these structures and mainly in the telencephalon.